{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Python TERMite toolkit - ScibiteSearch\n",
    "This notebook walks you through how to make calls to a ScibiteSearch API, using the functions from the toolkit."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Import the required sublibrary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from termite_toolkit import scibite_search"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Point to a ScibiteSearch server and then fill in the authentication details.\n",
    "\n",
    "- User: The username you use to login normally on Scibite Search\n",
    "- Password: The password for Scibite Search corresponding to this user.\n",
    "- Client id: The user for the token API. It can be found in the swagger API UI under the _Authorise_ pop-up."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "ss_home = 'https://scibitesearch-datascience.scibite.io'\n",
    "user = \"scibitesearch-admin-user\"\n",
    "password = \"jE7vC8kO9yH1hH8qF3\"\n",
    "client_id = \"scibitesearch\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Get Documents Query"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Below is an example call on how to use the toolkit to hit the Scibite Search API and retrieve the documents metadata for a given SSQL query.\n",
    "Documentation and examples on SSQL queries can be found in \n",
    "\n",
    "https://help.scibite.com/a/solutions/articles/4000175713?portalId=59454"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "('https://scibitesearch-datascience.scibite.io/api/search/v1/documents/?markup=True&limit=20&offset=0&queries=dataset%3D%22Medline%22+AND+GENE%24PDE5A',\n",
       " {'data': [{'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [inhibitors](BIOVERB$INHIBIT).',\n",
       "    'native_id': '12774696',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T18:40:46.932071Z',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_12774696',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_12774696'}},\n",
       "    '_score': 56.59189987182617,\n",
       "    '_snippets': {}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': 'Comparison of [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [inhibitors](BIOVERB$INHIBIT).',\n",
       "    'native_id': '16780568',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T20:14:25.050111Z',\n",
       "    '_summary': 'Of the current options available to [treat](BIOVERB$TREAT) [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION), [oral](BIOPROC$BP70410) [phosphodiesterase](PROTYP$PROTYP82&GENE$PDE5A&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](GENE$PDE5A)) [inhibitors](BIOVERB$INHIBIT) are the recommended first-line [treatment](BIOVERB$TREATMENT).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_16780568',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_16780568'}},\n",
       "    '_score': 56.3280143737793,\n",
       "    '_snippets': {'abstract': ['Of the current options available to [treat](BIOVERB$TREAT) [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION), [oral](BIOPROC$BP70410) [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [inhibitors](BIOVERB$INHIBIT) are the recommended first-line [treatment](BIOVERB$TREATMENT).',\n",
       "      'This review compares the three currently licensed [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT): [sildenafil](DRUG$CHEMBL192) [citrate](DRUG$CHEMBL192&LABCHEM$D002951) ([sildenafil](DRUG$CHEMBL192)), [vardenafil](DRUG$CHEMBL1520) [HCl](LABCHEM$D006851&DRUG$CHEMBL1520) ([vardenafil](DRUG$CHEMBL3769434&DRUG$CHEMBL1520)) and [tadalafil](DRUG$CHEMBL779).',\n",
       "      'These [pharmacokinetic](BIOPROC$D010599) differences among the [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) may underlie patient preference, an important and emerging aspect of ED therapy.',\n",
       "      'Another difference between the [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) is that food, especially fatty food, [affects](BIOVERB$AFFECT) the [pharmacokinetic](BIOPROC$D010599) profiles of [sildenafil](DRUG$CHEMBL192) and [vardenafil](DRUG$CHEMBL3769434&DRUG$CHEMBL1520), but not that of [tadalafil](DRUG$CHEMBL779).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': \"Isolation and characterization of cDNAs encoding [PDE5A](_hit_term=GENE$PDE5A), a [human](SPECIES$D006801) [cGMP-binding,](_hit_term=GENE$PDE5A&BIOCHEM$D006152&GOONTOL$GO0030553&DRUG$CHEMBL395336&BIOVERB$BIND) [cGMP-specific](_hit_term=GENE$PDE5A&BIOCHEM$D006152&DRUG$CHEMBL395336) [3',5'-cyclic](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114) [nucleotide](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114&PROTYP$PROTYP1096) [phosphodiesterase](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114&PROTYP$PROTYP1096).\",\n",
       "    'native_id': '9714779',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T17:14:37.386201Z',\n",
       "    '_summary': \"[Human](SPECIES$D006801) [cGMP-binding,](GENE$PDE5A&BIOCHEM$D006152&GOONTOL$GO0030553&DRUG$CHEMBL395336&BIOVERB$BIND) [cGMP-specific](GENE$PDE5A&BIOCHEM$D006152&DRUG$CHEMBL395336) [3',5'-cyclic](GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114) [nucleotide](GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114&PROTYP$PROTYP1096) [phosphodiesterase](GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114&PROTYP$PROTYP1096) ([PDE5A](GENE$PDE5A)) cDNAs were isolated.\",\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_9714779',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_9714779'}},\n",
       "    '_score': 55.555870056152344,\n",
       "    '_snippets': {'abstract': [\"[Human](SPECIES$D006801) [cGMP-binding,](_hit_term=GENE$PDE5A&BIOCHEM$D006152&GOONTOL$GO0030553&DRUG$CHEMBL395336&BIOVERB$BIND) [cGMP-specific](_hit_term=GENE$PDE5A&BIOCHEM$D006152&DRUG$CHEMBL395336) [3',5'-cyclic](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114) [nucleotide](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114&PROTYP$PROTYP1096) [phosphodiesterase](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0004114&PROTYP$PROTYP1096) ([PDE5A](_hit_term=GENE$PDE5A)) cDNAs were isolated.\",\n",
       "      '[PDE5A](_hit_term=GENE$PDE5A) maps to [chromosome](GOONTOL$GO0005694) 4q 25-27.',\n",
       "      'This activity was [inhibited](BIOVERB$INHIBIT) by the selective [PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17) [inhibitors](BIOVERB$INHIBIT) [zaprinast](LABCHEM$C011145&DRUG$CHEMBL28079) and DMPPO.',\n",
       "      '[PDE5A](_hit_term=GENE$PDE5A) [mRNA](BIOPROC$BP71171) is [expressed](BIOVERB$EXPRESS) in [aortic](CELLTYP$CL0002539&ANAT$U0004178) [smooth](CELLTYP$CL0002539&ANAT$U0004178) [muscle](CELLTYP$CL0002539&ANAT$U0004178) [cells](CELLTYP$CL0002539), [heart](ANAT$U0000948), [placenta](ANAT$U0001987), [skeletal muscle](ANAT$U0001134) and [pancreas](ANAT$U0001264) and, to a much lesser extent, in [brain](ANAT$U0000955), [liver](ANAT$U0002107) and [lung](ANAT$U0002048).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[The basics of [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [inhibition](BIOVERB$INHIBIT) in urology].',\n",
       "    'native_id': '18854969',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T21:20:36.543085Z',\n",
       "    '_summary': '[Phosphodiesterase](PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4) ([PDE](PROTYP$PROTYP82)) isoenzymes hold a central role in [controlling](BIOVERB$CONTROL) levels of the [cyclic nucleotide](BIOCHEM$D009712) monophosphates [cyclic AMP](BIOCHEM$D000242&DRUG$CHEMBL316966) and [cyclic GMP](BIOCHEM$D006152&DRUG$CHEMBL395336), which are important [second messengers](BIOPROC$D015290) in many transmitter [pathways](GOONTOL$GO0007165) involved in [regulating](BIOVERB$REGULATE) [biological processes](GOONTOL$GO0008150) in urogenital tissues.',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_18854969',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_18854969'}},\n",
       "    '_score': 55.36638641357422,\n",
       "    '_snippets': {'abstract': ['This review briefly describes the current and evolving advances in the field of [PDE5](_hit_term=GENE$PDE5A) pharmacotherapy in urology and other fields of medicine.',\n",
       "      'The development of the [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) [Sildenafil (Viagra)](DRUG$CHEMBL192), [Vardenafil](DRUG$CHEMBL3769434&DRUG$CHEMBL1520) ([Levitra](DRUG$CHEMBL1520)), and [Tadalafil](DRUG$CHEMBL779) ([Cialis](DRUG$CHEMBL779)), [combining](BIOVERB$COMBINE) a high [response](BIOVERB$RESPONSE) rate and the [advantage](BIOCHEM$D017137) of on-demand intake, is the result of the scientific characterization of the [physiology](BIOPROC$BP70055) of [penile](ANAT$U0000989) erectile [smooth muscle](ANAT$U0001135).The introduction of these compounds as safe and well-tolerated [orally active](BIOPROC$BP70410) drugs for the [treatment](BIOVERB$TREATMENT) of [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION) has not only become a worldwide clinical success, but it provided the basis for the development and introduction of several new therapeutic modalities into the management of [male](BIOPROC$BP71158) and [female](INDICATION$SDI0011) [sexual](INDICATION$SDI0011) [dysfunction](INDICATION$SDI0011&BIOVERB$DYSFUNCTION).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) is highly [expressed](BIOVERB$EXPRESS) in the hypertrophied [human](SPECIES$D006801) [right ventricle](ANAT$U0002080), and acute [inhibition](BIOVERB$INHIBIT) of [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [improves](BIOVERB$IMPROVE) [contractility](BIOPROC$BP70209).',\n",
       "    'native_id': '17638937',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T20:43:20.337403Z',\n",
       "    '_summary': 'The ability of [PDE5](GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) to [increase](BIOVERB$INCREASE) RV inotropy and to [decrease](BIOVERB$DECREASE) RV afterload without significantly [affecting](BIOVERB$AFFECT) systemic [hemodynamics](BIOPROC$D006439) makes them ideal for the [treatment](BIOVERB$TREATMENT) of diseases [affecting](BIOVERB$AFFECT) the RV, including [pulmonary](INDICATION$D006976&ANAT$U0002012) [arterial](INDICATION$D006976&ANAT$U0002012) [hypertension](INDICATION$D006976).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_17638937',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_17638937'}},\n",
       "    '_score': 55.12711715698242,\n",
       "    '_snippets': {'abstract': ['The ability of [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) to [increase](BIOVERB$INCREASE) RV inotropy and to [decrease](BIOVERB$DECREASE) RV afterload without significantly [affecting](BIOVERB$AFFECT) systemic [hemodynamics](BIOPROC$D006439) makes them ideal for the [treatment](BIOVERB$TREATMENT) of diseases [affecting](BIOVERB$AFFECT) the RV, including [pulmonary](INDICATION$D006976&ANAT$U0002012) [arterial](INDICATION$D006976&ANAT$U0002012) [hypertension](INDICATION$D006976).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Immunohistochemical](LABPROC$D007150&BIOPROC$BP70289) localization of [cGMP-binding](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&BIOCHEM$D006152&GOONTOL$GO0030553&ENZYMES$EC_3_1_4_35&DRUG$CHEMBL395336&BIOVERB$BIND) [cGMP-specific](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0047555&BIOCHEM$D006152&PROTYP$PROTYP3145&ENZYMES$EC_3_1_4_35&DRUG$CHEMBL395336) [phosphodiesterase](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0047555&PROTYP$PROTYP3145&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17)) in [rat](SPECIES$D051381) tissues.',\n",
       "    'native_id': '10769052',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T17:42:20.452476Z',\n",
       "    '_summary': 'We raised a [polyclonal](BIOPROC$BP71201) [antibody](BIOPROC$BP71047) against [maltose](GOONTOL$GO1901982&DRUG$CHEMBL1908365&BIOCHEM$D008320) [binding](GOONTOL$GO1901982&BIOVERB$BIND) protein fusion [human](SPECIES$D006801) [cGMP-binding,](GENE$PDE5A&ENZYMES$EC_3_1_4_17&BIOCHEM$D006152&GOONTOL$GO0030553&ENZYMES$EC_3_1_4_35&DRUG$CHEMBL395336&BIOVERB$BIND) [cGMP-specific](GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0047555&BIOCHEM$D006152&PROTYP$PROTYP3145&ENZYMES$EC_3_1_4_35&DRUG$CHEMBL395336) [phosphodiesterase](GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0047555&PROTYP$PROTYP3145&ENZYMES$EC_3_1_4_35) ([PDE5](GENE$PDE5A&ENZYMES$EC_3_1_4_17)) [produced](BIOVERB$PRODUCE) in [E. coli](SPECIES$D004926).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_10769052',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_10769052'}},\n",
       "    '_score': 55.06575012207031,\n",
       "    '_snippets': {'abstract': ['We raised a [polyclonal](BIOPROC$BP71201) [antibody](BIOPROC$BP71047) against [maltose](GOONTOL$GO1901982&DRUG$CHEMBL1908365&BIOCHEM$D008320) [binding](GOONTOL$GO1901982&BIOVERB$BIND) protein fusion [human](SPECIES$D006801) [cGMP-binding,](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&BIOCHEM$D006152&GOONTOL$GO0030553&ENZYMES$EC_3_1_4_35&DRUG$CHEMBL395336&BIOVERB$BIND) [cGMP-specific](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0047555&BIOCHEM$D006152&PROTYP$PROTYP3145&ENZYMES$EC_3_1_4_35&DRUG$CHEMBL395336) [phosphodiesterase](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17&GOONTOL$GO0047555&PROTYP$PROTYP3145&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17)) [produced](BIOVERB$PRODUCE) in [E. coli](SPECIES$D004926).',\n",
       "      'Here we described a cell-specific localization of [PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17) in various [rat](SPECIES$D051381) tissues, suggesting the possibility of the presence of a [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336)/[PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17) [pathway](BIOPROC$D015398&GOONTOL$GO0007165) in these tissues.',\n",
       "      'This [antibody](BIOPROC$BP71047) immunoreacted specifically with [recombinant](BIOPROC$D011995) [human](SPECIES$D006801) and [rat](SPECIES$D051381) [PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17) proteins [expressed](BIOVERB$EXPRESS) in [transfected](BIOPROC$D014162) COS-7 cells and with a native form of [PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17) in extracts of [rat](SPECIES$D051381) [platelets](CELLTYP$CL0000233), [lung](ANAT$U0002048), and [cerebellum](ANAT$U0002037).',\n",
       "      '[Reverse](LABPROC$D020133&ENZYMES$EC_2_7_7_49&GOONTOL$GO0003964) [transcriptase-polymerase](LABPROC$D020133&ENZYMES$EC_2_7_7_49&BIOPROC$BP71202&GOONTOL$GO0003964) [chain](LABPROC$D020133&BIOPROC$BP71202) [reaction](LABPROC$D020133&BIOPROC$BP71202) analysis demonstrated that [PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17) transcripts are also present in [rat](SPECIES$D051381) [cerebellum](ANAT$U0002037), [kidney](ANAT$U0002113), and [pancreas](ANAT$U0001264).',\n",
       "      '[Immunohistochemical](LABPROC$D007150&BIOPROC$BP70289) analysis showed that the anti-[PDE5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_17) [antibody](BIOPROC$BP71047) detected immunoactive materials in [Purkinje](CELLTYP$CL0000121&ANAT$U0002979) [cell](CELLTYP$CL0000121&ANAT$U0002979) [layers](ANAT$U0002979) of the [cerebellum](ANAT$U0002037), [proximal renal tubules](ANAT$U0004134), collecting [renal ducts](ANAT$U0006553), and [epithelial](CELLTYP$CL0000083&ANAT$U0000483) [cells](CELLTYP$CL0000083) [of](CELLTYP$CL0000083) [pancreatic](ANAT$U0007329&CELLTYP$CL0000083) [ducts](ANAT$U0007329) in [rats](SPECIES$D051381).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [regulation](BIOVERB$REGULATE) of [human](SPECIES$D006801) [sperm](CELLTYP$CL0000019&GOONTOL$GO0097722&BIOPROC$D013081) [motility](GOONTOL$GO0097722&BIOPROC$D013081).',\n",
       "    'native_id': '10819812',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T17:44:00.467584Z',\n",
       "    '_summary': 'These results suggest that [inhibition](BIOVERB$INHIBIT) of [type](GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](GENE$PDE5A&ENZYMES$EC_3_1_4_35) [phosphodiesterase](PROTYP$PROTYP82&GENE$PDE5A&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) activity in [human](SPECIES$D006801) [sperm](CELLTYP$CL0000019) resulted in [enhanced](BIOVERB$ENHANCE) progressive [motility](BIOPROC$BP70381) and [hyperactivation](BIOVERB$ACTIVATE).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_10819812',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_10819812'}},\n",
       "    '_score': 55.00502014160156,\n",
       "    '_snippets': {'abstract': ['In addition, [inhibition](BIOVERB$INHIBIT) of [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) also [caused](BIOVERB$CAUSE) an [increase](BIOVERB$INCREASE) in [acrosome](PROTYP$PROTYP1007&BIOPROC$D020101&GOONTOL$GO0007340) [reaction](BIOPROC$D020101&GOONTOL$GO0007340).',\n",
       "      'These results suggest that [inhibition](BIOVERB$INHIBIT) of [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) activity in [human](SPECIES$D006801) [sperm](CELLTYP$CL0000019) resulted in [enhanced](BIOVERB$ENHANCE) progressive [motility](BIOPROC$BP70381) and [hyperactivation](BIOVERB$ACTIVATE).',\n",
       "      'This suggests a role for [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) in [preventing](BIOVERB$PREVENT) premature [acrosome](PROTYP$PROTYP1007&BIOPROC$D020101&GOONTOL$GO0007340) [reaction](BIOPROC$D020101&GOONTOL$GO0007340), which is [associated](BIOVERB$ASSOCIATE) with failed [fertilization](GOONTOL$GO0009566&BIOPROC$D005306).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT): unmet needs.',\n",
       "    'native_id': '19860693',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T21:53:00.896254Z',\n",
       "    '_summary': '[Erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION) (ED) has been revolutionized during the last two decades, as several [treatment](BIOVERB$TREATMENT) options are available today.',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_19860693',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_19860693'}},\n",
       "    '_score': 54.935951232910156,\n",
       "    '_snippets': {'abstract': ['[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [inhibitors](BIOVERB$INHIBIT) ([sildenafil](DRUG$CHEMBL192), [tadalafil](DRUG$CHEMBL779), [vardenafil](DRUG$CHEMBL3769434&DRUG$CHEMBL1520)) are currently the first choice [treatment](BIOVERB$TREATMENT) option for ED by most physicians and patients due to their high [efficacy](LABPROC$LPC0061&BIOPROC$BP70235) rates and favourable safety profiles.']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Novel indications for [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT)].',\n",
       "    'native_id': '17694282',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T20:46:14.500266Z',\n",
       "    '_summary': '[Phosphodiesterase](PROTYP$PROTYP82&GENE$PDE5A&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](GENE$PDE5A)) [induces](BIOVERB$INDUCE) the breakdown of cyclic [guanosine monophosphate](BIOCHEM$D006152&DRUG$CHEMBL283807&BIOCHEM$D006157) ([cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336)) in [smooth](ANAT$U0001135&CELLTYP$CL0000192) [muscle](ANAT$U0001135&CELLTYP$CL0000192) [cells](CELLTYP$CL0000192).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_17694282',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_17694282'}},\n",
       "    '_score': 54.76190185546875,\n",
       "    '_snippets': {'abstract': ['[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [induces](BIOVERB$INDUCE) the breakdown of cyclic [guanosine monophosphate](BIOCHEM$D006152&DRUG$CHEMBL283807&BIOCHEM$D006157) ([cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336)) in [smooth](ANAT$U0001135&CELLTYP$CL0000192) [muscle](ANAT$U0001135&CELLTYP$CL0000192) [cells](CELLTYP$CL0000192).',\n",
       "      'Hence, [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) [promote](BIOVERB$PROMOTE) [vasodilative](BIOPROC$D014664) [effects](BIOVERB$EFFECT) by [enhancing](BIOVERB$ENHANCE) [intracellular](GOONTOL$GO0005622) [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336) levels.',\n",
       "      'Three [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT), [sildenafil](DRUG$CHEMBL192), [vardenafil](DRUG$CHEMBL3769434&DRUG$CHEMBL1520), and [tadalafil](DRUG$CHEMBL779), have been approved for the [treatment](BIOVERB$TREATMENT) of \"[erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION)\" (ED).',\n",
       "      'This review describes the cardiovascular safety of [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) and provides an overview of the current literature regarding potential novel indications.',\n",
       "      \"Recent experimental studies and clinical trials indicate that [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) are also effective in the [treatment](BIOVERB$TREATMENT) of various other diseases such as [pulmonary](INDICATION$D006976&ANAT$U0002012) [arterial](INDICATION$D006976&ANAT$U0002012) [hypertension](INDICATION$D006976) ([PAH](INDICATION$D006976)), [Raynaud's disease](INDICATION$D011928), [gastrointestinal disorders](INDICATION$D005767), and [stroke](INDICATION$D020521), and furthermore [exert](BIOVERB$EXERT) [cardioprotective](BIOPROC$BP70184) [effects](BIOVERB$EFFECT).\"]}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Sildenafil](DRUG$CHEMBL192) [Citrate](DRUG$CHEMBL192&LABCHEM$D002951), a Selective [Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [Type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [Inhibitor](BIOVERB$INHIBIT):',\n",
       "    'native_id': '10322402',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T17:28:09.229924Z',\n",
       "    '_summary': 'Under normal [physiological](BIOPROC$BP70055) conditions, following sexual [stimulation](BIOVERB$STIMULATE), [release](BIOVERB$RELEASE) of [nitric oxide](DRUG$CHEMBL1200689&BIOCHEM$D009569&LABCHEM$D009569) (NO) from [penile](ANAT$U0000989) non-adrenergic, non-cholinergic [nerves](ANAT$U0001021) and the [endothelium](ANAT$U0001986) [activates](BIOVERB$ACTIVATE&BIOPROC$BP71044) [guanylyl cyclase](PROTYP$PROTYP563&GOONTOL$GO0004383&ENZYMES$EC_4_6_1_2) and [induces](BIOVERB$INDUCE) [intracellular](GOONTOL$GO0005622) [cGMP](BIOCHEM$D006152&GOONTOL$GO0006182&DRUG$CHEMBL395336) [synthesis](GOONTOL$GO0006182) in [erectile tissue](ANAT$U0008324) trabecular [smooth](ANAT$U0001135&CELLTYP$CL0000192) [muscle](ANAT$U0001135&CELLTYP$CL0000192) [cells](CELLTYP$CL0000192).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_10322402',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_10322402'}},\n",
       "    '_score': 54.67607879638672,\n",
       "    '_snippets': {'abstract': ['[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A) [5](_hit_term=GENE$PDE5A)) is the predominant [enzyme](GOONTOL$GO0003824) responsible for [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336) [hydrolysis](BIOPROC$D006868) in trabecular [smooth muscle](ANAT$U0001135).',\n",
       "      '[Sildenafil](DRUG$CHEMBL192) [citrate](DRUG$CHEMBL192&LABCHEM$D002951) is a [potent](BIOPROC$BP70448) [PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A) [5](_hit_term=GENE$PDE5A) reversible and selective [inhibitor](BIOVERB$INHIBIT) that [blocks](BIOVERB$BLOCK) [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336) [hydrolysis](BIOPROC$D006868) effectively (Ki approximately 3 nM).',\n",
       "      '[Activation](BIOVERB$ACTIVATE&BIOPROC$BP71044) of [PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A) [5](_hit_term=GENE$PDE5A) terminates NO-[induced](BIOVERB$INDUCE), [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336)-[mediated](BIOVERB$MEDIATE) [smooth](ANAT$U0001135&GOONTOL$GO0044557) [muscle](ANAT$U0001135&GOONTOL$GO0044557&BIOPROC$D009126) [relaxation](GOONTOL$GO0044557&BIOPROC$D009126), resulting ultimately in restoration of basal [smooth muscle](ANAT$U0001135) [contractility](BIOPROC$BP70209) and [penile](ANAT$U0000989) flaccidity.']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [inhibitors](BIOVERB$INHIBIT) for the [treatment](BIOVERB$TREATMENT) of [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION).',\n",
       "    'native_id': '20402554',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T22:07:58.61719Z',\n",
       "    '_summary': 'PDE5i will remain the mainstay initial medical [treatment](BIOVERB$TREATMENT) for ED and will play a larger role in the [treatment](BIOVERB$TREATMENT) of other medical conditions. Novel formulations in this class will allow patients to select agents that best suit their needs.',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_20402554',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_20402554'}},\n",
       "    '_score': 54.62329864501953,\n",
       "    '_snippets': {}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35): expanding roles in cardiovascular [regulation](BIOVERB$REGULATE).',\n",
       "    'native_id': '18040025',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T20:55:11.204181Z',\n",
       "    '_summary': '[Phosphodiesterase](PROTYP$PROTYP82&GENE$PDE5A&GOONTOL$GO0008081) [type](GENE$PDE5A) [5A](GENE$PDE5A) ([PDE5A](GENE$PDE5A)) selectively [hydrolyzes](BIOVERB$HYDROLYSE) [cyclic GMP](BIOCHEM$D006152&DRUG$CHEMBL395336).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_18040025',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_18040025'}},\n",
       "    '_score': 54.61117172241211,\n",
       "    '_snippets': {'abstract': ['[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081) [type](_hit_term=GENE$PDE5A) [5A](_hit_term=GENE$PDE5A) ([PDE5A](_hit_term=GENE$PDE5A)) selectively [hydrolyzes](BIOVERB$HYDROLYSE) [cyclic GMP](BIOCHEM$D006152&DRUG$CHEMBL395336).',\n",
       "      'In this review, we discuss the molecular biology, [pharmacology](BIOPROC$BP70434), and [physiology](BIOPROC$BP70055) of [PDE5A](_hit_term=GENE$PDE5A), mechanisms of [vascular](ANAT$U0002049) and [cardiac](ANAT$U0000948) [regulation](BIOVERB$REGULATE), and recent evidence supporting the utility of selective [PDE5A](_hit_term=GENE$PDE5A) [inhibition](BIOVERB$INHIBIT) for the [treatment](BIOVERB$TREATMENT) of [cardiovascular disorders](INDICATION$D002318).',\n",
       "      '[PDE5A](_hit_term=GENE$PDE5A) plays an important role in the [pulmonary vasculature](ANAT$U0000102) where its [inhibition](BIOVERB$INHIBIT) benefits patients with [pulmonary](ANAT$U0002048&INDICATION$D006976) [hypertension](INDICATION$D006976).',\n",
       "      'In disorders such as [cardiac](INDICATION$D006333&ANAT$U0000948) [failure](INDICATION$D006333), [PDE5A](_hit_term=GENE$PDE5A) [upregulation](BIOVERB$UPREGULATE) may contribute to a decline in [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336) and [protein](GOONTOL$GO0004672&GENE$PRKG1&ENZYMES$EC_2_7_11_12) [kinase](GOONTOL$GO0004672&GENE$PRKG1&ENZYMES$EC_2_7_11_12) [G](GENE$PRKG1&ENZYMES$EC_2_7_11_12) signaling, [exacerbating](BIOVERB$EXACERBATE) [dysfunction](BIOVERB$DYSFUNCTION).',\n",
       "      '[Inhibitors](BIOVERB$INHIBIT) of [PDE5A](_hit_term=GENE$PDE5A) such as [sildenafil](DRUG$CHEMBL192) are widely used to [treat](BIOVERB$TREAT) [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION), but [growing](BIOVERB$GROW) evidence supports important roles for the [enzyme](GOONTOL$GO0003824) in both the [vasculature](ANAT$U0002049) and [heart](ANAT$U0000948).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) inhibithors in older [males](BIOPROC$BP71158).',\n",
       "    'native_id': '16760638',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T20:13:47.545031Z',\n",
       "    '_summary': 'Although [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION) (ED) in older subjects needs a holistic approach, the pathophysiology consists mainly in chronic [ischemia](INDICATION$D007511) with [deterioration](BIOVERB$DETERIORATE) of cavernous [smooth muscles](ANAT$U0001135) followed by development of corporeal [fibrosis](INDICATION$D005355).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_16760638',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_16760638'}},\n",
       "    '_score': 54.577842712402344,\n",
       "    '_snippets': {'abstract': ['Therefore, [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [inhibition](BIOVERB$INHIBIT), [enhancing](BIOVERB$ENHANCE) [vasodilatation](GOONTOL$GO0042311&BIOPROC$D014664) in corpora cavernosa, represents a first-line therapy for ED.',\n",
       "      '[PDE5](_hit_term=GENE$PDE5A) is in fact the major [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336) hydrolizing [enzyme](GOONTOL$GO0003824) in [penile](ANAT$U0000989) [corpus cavernosum](ANAT$U0006609).',\n",
       "      'Furthermore, attention is focused on the [interaction](BIOVERB$INTERACT) of [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) on [hypothalamus](ANAT$U0001898)-[pituitary](ANAT$U0000007) gonadol (HPG) function.',\n",
       "      'The mechanisms of [action](BIOVERB$ACT), the [pharmacokinetics](BIOPROC$D010599) and the contraindications of selective [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT), are described in details.',\n",
       "      'Finally, considering that [androgens](BIOCHEM$BIOCH0008&PROTYP$PROTYP378) may [influence](BIOVERB$INFLUENCE) sexual behavior by [modifying](BIOVERB$MODIFY) the [central](ANAT$U0001017) [nervous](ANAT$U0001017&BIOPROC$BP71174) [system](ANAT$U0001017&BIOPROC$BP71174) [neurotransmitter](PROTYP$PROTYP413&BIOPROC$BP71175) targeted system, the [potentiation](BIOVERB$POTENTIATE) of [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) with [testosterone](BIOCHEM$D013739) supplementation may be considered to [improve](BIOVERB$IMPROVE) erectile function and quality of life in older [males](BIOPROC$BP71158).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) in the [adipocyte](CELLTYP$CL0000136): a novel player in fat [metabolism](BIOPROC$D008660&GOONTOL$GO0008152)?',\n",
       "    'native_id': '21741267',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T22:47:08.864835Z',\n",
       "    '_summary': '[Phosphodiesterase](PROTYP$PROTYP82&GENE$PDE5A&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](GENE$PDE5A)) is [expressed](BIOVERB$EXPRESS) in many tissues (e.g.',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_21741267',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_21741267'}},\n",
       "    '_score': 54.54615783691406,\n",
       "    '_snippets': {'abstract': ['[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) is [expressed](BIOVERB$EXPRESS) in many tissues (e.g. [heart](ANAT$U0000948), [lung](ANAT$U0002048), [pancreas](ANAT$U0001264), [penis](ANAT$U0000989)) and plays a specific role in hydrolyzing cyclic [guanosine monophosphate](BIOCHEM$D006152&DRUG$CHEMBL283807&BIOCHEM$D006157) ([cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336)).',\n",
       "      'Interestingly, [PDE5](_hit_term=GENE$PDE5A) was recently identified in [adipose tissue](ANAT$U0001013), although its role remains unclear.',\n",
       "      'A better elucidation of the role of [PDE5](_hit_term=GENE$PDE5A) in the [adipocyte](CELLTYP$CL0000136) could reveal new therapeutic strategies for fighting [obesity](INDICATION$D009765) and [metabolic syndrome](INDICATION$D008659).',\n",
       "      'This review summarizes evidence supporting a role for the [PDE5](_hit_term=GENE$PDE5A)-[regulated](BIOVERB$REGULATE) [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336)/[PKG](ENZYMES$EC_2_7_11_12&PROTYP$PROTYP3146) system in [adipose tissue](ANAT$U0001013) and its [effects](BIOVERB$EFFECT) on [adipocyte](CELLTYP$CL0000136) function.']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT) and [kidney](INDICATION$D007674&ANAT$U0002113) [disease](INDICATION$D007674).',\n",
       "    'native_id': '26242375',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-21T01:39:54.597099Z',\n",
       "    '_summary': '[Chronic](INDICATION$D051436) [kidney](ANAT$U0002113&INDICATION$D051436) [disease](INDICATION$D051436) ([CKD](INDICATION$D051436)) represents a worldwide health problem.',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_26242375',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_26242375'}},\n",
       "    '_score': 54.53399658203125,\n",
       "    '_snippets': {'abstract': ['[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE5](_hit_term=GENE$PDE5A)) [inhibitors](BIOVERB$INHIBIT) represent a class of drugs traditionally used to [treat](BIOVERB$TREAT) [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION) and [pulmonary](ANAT$U0002048&INDICATION$D006976) [hypertension](INDICATION$D006976).',\n",
       "      \"In the current review, we summarize [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT)' utility in disease states and clinical conditions related to [kidney](INDICATION$D007674&ANAT$U0002113) [disease](INDICATION$D007674) such as systemic [hypertension](INDICATION$D006973) and acute and chronic [kidney](ANAT$U0002113) injury and discuss the mechanisms explaining possible [kidney](ANAT$U0002113) [protective](BIOVERB$PROTECTIVE) roles of [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT).\",\n",
       "      'However, recent evidence suggests that [PDE5](_hit_term=GENE$PDE5A) [inhibitors](BIOVERB$INHIBIT) may have additional therapeutic [effects](BIOVERB$EFFECT), such as [cardioprotection](BIOPROC$BP70184) and cerebrovascular [protection](BIOVERB$PROTECT).',\n",
       "      'A recently completed [phase](BIOPROC$D016196) 2 trials demonstrated that the [long](BIOPROC$BP70032)-[acting](BIOVERB$ACT) [PDE5](_hit_term=GENE$PDE5A) [inhibitor](BIOVERB$INHIBIT) [PF-00489791](LABCHEM$C000619499&DRUG$MAND00268) [decreased](BIOVERB$DECREASE) [albuminuria](INDICATION$D000419) in patients with overt [diabetic nephropathy](INDICATION$D003928) when added on top of [renin-angiotensin](ANAT$U0018229&BIOPROC$D012084&GENE$REN&GENE$AGT&BIOCHEM$BIOCH090317&ENZYMES$EC_3_4_23_15&PROTYP$PROTYP3412) [system](ANAT$U0018229&BIOPROC$D012084) blockade.']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[[Erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION) and [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT)].',\n",
       "    'native_id': '12891884',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T18:44:21.93768Z',\n",
       "    '_summary': '[Erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION) [affects](BIOVERB$AFFECT) 150 millions of men and its prevalence [increases](BIOVERB$INCREASE) with age.',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_12891884',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_12891884'}},\n",
       "    '_score': 54.456748962402344,\n",
       "    '_snippets': {'abstract': ['The authors relate the widespread interest in [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT) with the advent of [sildenafil](DRUG$CHEMBL192) for the [treatment](BIOVERB$TREATMENT) of [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION) and present characteristics of 2 new [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT) in Belgium, [tadalafil](DRUG$CHEMBL779) and [vardenafil](DRUG$CHEMBL3769434&DRUG$CHEMBL1520).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT): a biochemical and clinical [correlation](BIOVERB$CORRELATE) survey.',\n",
       "    'native_id': '14551572',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T19:08:34.954207Z',\n",
       "    '_summary': '[Phosphodiesterase](PROTYP$PROTYP82&GENE$PDE5A&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE](PROTYP$PROTYP82&GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](GENE$PDE5A&ENZYMES$EC_3_1_4_35)) is the major [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336) hydrolyzing [enzyme](GOONTOL$GO0003824) in [penile](ANAT$U0000989) [corpus cavernosum](ANAT$U0006609) and is an important [regulator](BIOVERB$REGULATE) of [nitric oxide](DRUG$CHEMBL1200689&BIOCHEM$D009569&LABCHEM$D009569)-[mediated](BIOVERB$MEDIATE) [smooth](ANAT$U0001135&GOONTOL$GO0044557) [muscle](ANAT$U0001135&GOONTOL$GO0044557&BIOPROC$D009126) [relaxation](GOONTOL$GO0044557&BIOPROC$D009126).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_14551572',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_14551572'}},\n",
       "    '_score': 54.45207595825195,\n",
       "    '_snippets': {'abstract': ['[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35)) is the major [cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336) hydrolyzing [enzyme](GOONTOL$GO0003824) in [penile](ANAT$U0000989) [corpus cavernosum](ANAT$U0006609) and is an important [regulator](BIOVERB$REGULATE) of [nitric oxide](DRUG$CHEMBL1200689&BIOCHEM$D009569&LABCHEM$D009569)-[mediated](BIOVERB$MEDIATE) [smooth](ANAT$U0001135&GOONTOL$GO0044557) [muscle](ANAT$U0001135&GOONTOL$GO0044557&BIOPROC$D009126) [relaxation](GOONTOL$GO0044557&BIOPROC$D009126).',\n",
       "      'The critical role of [PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) in [penile](ANAT$U0000989&INDICATION$D007172&BIOPROC$D010410&GOONTOL$GO0043084) [erection](INDICATION$D007172&BIOPROC$D010410&GOONTOL$GO0043084) and the recent availability of specific and [potent](BIOPROC$BP70448) [inhibitors](BIOVERB$INHIBIT) of [PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) have enabled the development of effective [oral](BIOPROC$BP70410) [treatment](BIOVERB$TREATMENT&BIOPROC$BP70410) strategies that have been widely accepted by both health-care professionals and the lay public.',\n",
       "      'This article examines the [correlation](BIOVERB$CORRELATE) between the available biochemical and clinical data for the [PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT) [sildenafil (Viagra)](DRUG$CHEMBL192), [tadalafil](DRUG$CHEMBL779) ([Cialis](DRUG$CHEMBL779)) and [vardenafil](DRUG$CHEMBL3769434&DRUG$CHEMBL1520) ([Levitra](DRUG$CHEMBL1520)).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT): the day after.',\n",
       "    'native_id': '16949200',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-20T20:20:16.423558Z',\n",
       "    '_summary': 'The data indicate the necessity for (1) exploration of the [pharmacologic](BIOPROC$BP70434) characteristics of the three [PDE5](GENE$PDE5A)-Is; (2) research on their [pharmacologic](BIOPROC$BP70434) differences because some [actions](BIOVERB$ACT) seems to be drug-specific; (3) development of alternative management strategies, such as chronic, low, everyday doses of [PDE5](GENE$PDE5A)-Is, if the monthly cost is affordable; and (4) clinical trials on use of [PDE5](GENE$PDE5A)-Is to [treat](BIOVERB$TREAT) other chronic conditions.',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_16949200',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_16949200'}},\n",
       "    '_score': 54.4236946105957,\n",
       "    '_snippets': {'abstract': ['The data indicate the necessity for (1) exploration of the [pharmacologic](BIOPROC$BP70434) characteristics of the three [PDE5](_hit_term=GENE$PDE5A)-Is; (2) research on their [pharmacologic](BIOPROC$BP70434) differences because some [actions](BIOVERB$ACT) seems to be drug-specific; (3) development of alternative management strategies, such as chronic, low, everyday doses of [PDE5](_hit_term=GENE$PDE5A)-Is, if the monthly cost is affordable; and (4) clinical trials on use of [PDE5](_hit_term=GENE$PDE5A)-Is to [treat](BIOVERB$TREAT) other chronic conditions.',\n",
       "      'The door for innovative therapeutic approaches will open, specifically for cross-[risk](BIOVERB$RISK) factor [treatment](BIOVERB$TREATMENT) with [PDE5](_hit_term=GENE$PDE5A)-Is or their use in combination [treatments](BIOVERB$TREATMENTS) or new multimodal pills that take [advantage](BIOCHEM$D017137) of drugs that [exert](BIOVERB$EXERT) pleiotropic [vascular](ANAT$U0002049) [actions](BIOVERB$ACT).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Upregulation](BIOVERB$UPREGULATE) of [Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) in the [Hyperplastic](INDICATION$D011470) [Prostate](ANAT$U0002367&INDICATION$D011470).',\n",
       "    'native_id': '26657792',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-21T02:01:27.30312Z',\n",
       "    '_summary': 'Both [erectile](INDICATION$D007172) [dysfunction](INDICATION$D007172&BIOVERB$DYSFUNCTION) (ED) and [lower](ANAT$U0001556&INDICATION$D059411) [urinary](ANAT$U0001556&INDICATION$D059411) [tract](ANAT$U0001556&INDICATION$D059411) [symptoms](INDICATION$D059411) (LUTS)/[benign](INDICATION$D011470) [prostatic](ANAT$U0002367&INDICATION$D011470) [hyperplasia](INDICATION$D011470) ([BPH](INDICATION$D011470)) are common in the [aging](GOONTOL$GO0007568) [male](BIOPROC$BP71158).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_26657792',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_26657792'}},\n",
       "    '_score': 54.39780807495117,\n",
       "    '_snippets': {'abstract': ['Numerous clinical trials have demonstrated the [efficacy](LABPROC$LPC0061&BIOPROC$BP70235) and safety of [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT) ([PDE5](_hit_term=GENE$PDE5A)-Is) for [treating](BIOVERB$TREAT) LUTS/[BPH](INDICATION$D011470) with/without ED.',\n",
       "      '[PDE5](_hit_term=GENE$PDE5A) [localized](BIOVERB$LOCALISE) mainly in fibromuscular [stroma](ANAT$U0003891) in [prostate](ANAT$U0002367).',\n",
       "      'The [upregulation](BIOVERB$UPREGULATE) of [PDE5](_hit_term=GENE$PDE5A) in the [hyperplastic](INDICATION$D011470) [prostate](ANAT$U0002367&INDICATION$D011470) could explain the mechanism and contribute to the high effectiveness of [PDE5](_hit_term=GENE$PDE5A)-Is for [treating](BIOVERB$TREAT) LUTS/[BPH](INDICATION$D011470).',\n",
       "      '[PDE5](_hit_term=GENE$PDE5A) was further analyzed with [Western-blot](LABPROC$D015153&BIOPROC$BP71244) and [histological](BIOPROC$BP70270) examination.',\n",
       "      'Fibromuscular [stroma](ANAT$U0003891) could be the main [target](BIOPROC$BP71232) for [PDE5](_hit_term=GENE$PDE5A)-Is within [prostate](ANAT$U0002367).']}},\n",
       "   {'schema_id': 'journal_abstract',\n",
       "    'title': '[Diabetic nephropathy](INDICATION$D003928): [Treatment](BIOVERB$TREATMENT) with [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT).',\n",
       "    'native_id': '23961322',\n",
       "    'dataset_id': '06efe2ee-e873-4c7d-b2df-340f02173abe',\n",
       "    'dataset': 'Medline',\n",
       "    'ingest_date': '2021-09-21T00:00:04.186287Z',\n",
       "    '_summary': 'The importance of [nitric oxide](DRUG$CHEMBL1200689&BIOCHEM$D009569&LABCHEM$D009569) (NO) in [vascular](ANAT$U0002049) [physiology](BIOPROC$BP70055) is irrefutable; it [stimulates](BIOVERB$STIMULATE) the [intracellular](GOONTOL$GO0005622) [production](BIOVERB$PRODUCTION) of cyclic [guanosine monophosphate](BIOCHEM$D006152&DRUG$CHEMBL283807&BIOCHEM$D006157) ([cGMP](BIOCHEM$D006152&DRUG$CHEMBL395336)), [initiating](BIOVERB$INITIATE) [vascular](ANAT$U0004237&GOONTOL$GO0060087) [smooth](ANAT$U0004237&GOONTOL$GO0060087) [muscle](ANAT$U0004237&BIOPROC$D009126&GOONTOL$GO0060087) [relaxation](BIOPROC$D009126&GOONTOL$GO0060087).',\n",
       "    'id': '06efe2ee-e873-4c7d-b2df-340f02173abe_23961322',\n",
       "    '_links': {'self': {'href': 'https://scibitesearch-datascience.scibite.io/api/search/v1/documents/06efe2ee-e873-4c7d-b2df-340f02173abe_23961322'}},\n",
       "    '_score': 54.38644027709961,\n",
       "    '_snippets': {'keywords': ['[Angiotensin](BIOCHEM$D000804&PROTYP$PROTYP2144&DRUG$CHEMBL2391146) [II](BIOCHEM$D000804&PROTYP$PROTYP2144);[Diabetic nephropathy](INDICATION$D003928);[Glomerular](BIOPROC$D005919&GOONTOL$GO0003094) [filtration](BIOPROC$D005919&LABPROC$D005374&GOONTOL$GO0003094) [rate](BIOPROC$D005919&GOONTOL$GO0003094);[Inflammation](INDICATION$D007249);[Phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35)'],\n",
       "     'abstract': ['It is now evident that the [vascular](ANAT$U0002049) [production](BIOVERB$PRODUCTION&GOONTOL$GO0006182) [of](GOONTOL$GO0006182) [cGMP](BIOCHEM$D006152&GOONTOL$GO0006182&DRUG$CHEMBL395336) can be [augmented](BIOVERB$AUGMENT) by [inhibitors](BIOVERB$INHIBIT) of [phosphodiesterase](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&GOONTOL$GO0008081&ENZYMES$EC_3_1_4_35) [type](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) ([PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35)), the [enzyme](GOONTOL$GO0003824) which [breakdowns](GOONTOL$GO0009056) this [cyclic nucleotide](BIOCHEM$D009712).',\n",
       "      '[PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT) may have, therefore, the potential to [reduce](BIOVERB$REDUCE) glomerular [hypertension](INDICATION$D006973).',\n",
       "      'This review describes the use of [PDE](_hit_term=GENE$PDE5A&PROTYP$PROTYP82&ENZYMES$EC_3_1_4_35) [5](_hit_term=GENE$PDE5A&ENZYMES$EC_3_1_4_35) [inhibitors](BIOVERB$INHIBIT) to [improve](BIOVERB$IMPROVE) the metabolic, [haemodynamic](BIOPROC$D006439) and [inflammatory](INDICATION$D007249) [pathways](GOONTOL$GO0007165)/[responses](BIOVERB$RESPONSE), all of which are dysfunctional in DN.']}}],\n",
       "  'pagination': {'totalItems': 5482, 'maxOffset': 5482},\n",
       "  'queries': [{'query': 'dataset=\"Medline\" AND GENE$PDE5A'}],\n",
       "  'additionalFilters': []})"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "s = scibite_search.SBSRequestBuilder()\n",
    "s.set_url('https://scibitesearch-datascience.scibite.io')\n",
    "s.set_oauth2(\"scibitesearch\",\"scibitesearch-admin-user\",\"jE7vC8kO9yH1hH8qF3\")\n",
    "s.get_docs('dataset=\"Medline\" AND GENE$PDE5A')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
